Recent Mergers and Acquisitions
Celgene Acquisition by Bristol-Myers Squibb
Celgene Corporation (NASDAQ: CELG) and Bristol-Myers Squibb Company (NYSE: BMY), a Delaware corporation, agreed to a Plan of Merger, dated as of January 2, 2019.
Morrow Sodali served as proxy solicitor for this transaction.
Find more information here
Topics
Celgene Acquisition by Bristol-Myers Squibb
Topics
Celgene Corporation (NASDAQ: CELG) and Bristol-Myers Squibb Company (NYSE: BMY), a Delaware corporation, agreed to a Plan of Merger, dated as of January 2, 2019.
Morrow Sodali served as proxy solicitor for this transaction.
Find more information here